Recent Updates
Recently added Catalysts
EUDA Positive Sentiment Score: 70/100

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant SINGAPORE

Key Takeaway: EUDA Health Holdings Limited has announced the successful repurchase and cancellation of a warrant issued to Streeterville Capital, LLC, eliminating the potential issuance of 2,000,000 ordinary shares. The repurchase was completed for a total of US$125,000 as part of a securities purchase agreement made in November 2025. This strategic action demonstrates EUDA's commitment to maintaining shareholder value while focusing on the growing longevity healthcare market in Asia.

Market Sentiment Analysis

POSITIVE FACTORS

  • EUDA has successfully eliminated potential dilution by canceling the warrant.
  • The purchase cost of the warrant was relatively low at US$125,000.
  • This strategic move may strengthen shareholder confidence.
  • EUDA's focus on the longevity sector addresses growing healthcare needs in Asia.

Full Press Release Details

Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
March 04, 2026 (GLOBE NEWSWIRE) - EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"),
a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has repurchased
and cancelled in full the warrant previously issued to Streeterville Capital, LLC.
previously disclosed, the Company entered into a securities purchase agreement dated November 26, 2025 with an accredited investor for
the purchase of a warrant that was immediately exercisable into up to 2,000,000 newly issued ordinary shares of the Company. The warrant
was previously amended on December 16, 2025 and January 13, 2026.
February 27, 2026, the Company repurchased the warrant in full for a total purchase price of US$125,000. Following the repurchase, the
warrant was cancelled and is no longer outstanding.
a result of this transaction, there are no warrants remaining under this agreement, and the potential issuance of shares associated with
the warrant has been fully eliminated.
EUDA Health Holdings Limited
Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore,
Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the
fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which
is experiencing significant demographic shifts as more than 30% of the population ages rapidly. By offering innovative, accessible, and
science-backed health solutions, EUDA is positioned to lead the transformation of regional healthcare from reactive medical treatment
to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.
document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words,
such as the words "estimates," "projected," "expects," "envisions," "anticipates,"
"forecasts," "plans," "intends," "believes," "seeks," "may,"
"will," "should," "future," "propose" and variations of these words or similar expressions
(or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions
or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are
outside EUDA's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking
statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document.
The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.
Phone: +852 2117 0861

Frequently Asked Questions

What significant financial action did EUDA take recently?

EUDA repurchased and cancelled the warrant issued to Streeterville Capital, LLC.

How much did EUDA pay to repurchase the warrant?

The total purchase price for the warrant was US$125,000.

What does EUDA Health Holdings focus on?

EUDA focuses on non-invasive healthcare and preventive solutions in Asia.

When was the warrant originally issued?

The warrant was originally issued under a purchase agreement dated November 26, 2025.

What is EUDA's mission in healthcare?

EUDA aims to transform healthcare from reactive treatment to proactive care.

Last updated: Mar 4, 2026